Literature DB >> 25544823

Polycythemia vera presenting as acute myocardial infarction: An unusual presentation.

Hussain Bahbahani1, Khaled Aljenaee2, Abdelhaleem Bella3.   

Abstract

Acute myocardial infarction (AMI) is usually seen in the setting of atherosclerosis and its associated risk factors. Myocardial infarction in the young poses a particular challenge, as the disease is less likely, due to atherosclerosis. We report the case of a 37-year-old female patient who presented with ST segment elevation anterolateral AMI. The only abnormality on routine blood investigation was raised hemoglobin and hematocrit. After further testing, she was diagnosed according to the World Health Organization (WHO) criteria with polycythemia vera. This case illustrates the importance of recognizing polycythemia vera as an important cause of thrombosis, which can present initially as AMI, and to emphasize the early recognition of the disease in order to initiate appropriate management strategies.

Entities:  

Keywords:  Myocardial infarction; Polycythemia vera (PV)

Year:  2014        PMID: 25544823      PMCID: PMC4274309          DOI: 10.1016/j.jsha.2014.07.003

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  19 in total

Review 1.  Current management in polycythemia vera.

Authors:  H S Gilbert
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

2.  Recurrent coronary stent thrombosis.

Authors:  P Goethals; S Evrard; C Dubois
Journal:  Acta Cardiol       Date:  2000-12       Impact factor: 1.718

3.  Myocardial infarction as the initial manifestation of polycythemia vera.

Authors:  J B VACCA; G E THOMA
Journal:  AMA Arch Intern Med       Date:  1959-06

4.  Myocardial infarction as the initial manifestation of polycthemia vera.

Authors:  L WIRTH
Journal:  Mil Med       Date:  1960-08       Impact factor: 1.437

Review 5.  Polycythemia vera: new clinicopathologic perspectives.

Authors:  Ming Cao; Randall J Olsen; Youli Zu
Journal:  Arch Pathol Lab Med       Date:  2006-08       Impact factor: 5.534

6.  Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis.

Authors:  Yong Zhang; Hai-qin Tang; Jin Li; Zhao-xin Fu
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

7.  Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.

Authors:  Sandra Malak; Myriam Labopin; Cecile Saint-Martin; Christine Bellanne-Chantelot; Albert Najman
Journal:  Blood Cells Mol Dis       Date:  2012-07-19       Impact factor: 3.039

8.  [Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera].

Authors:  Meltem Tekin; Serkan Gökaslan; Erdem Diker; Sinan Aydoğdu
Journal:  Turk Kardiyol Dern Ars       Date:  2008-01

9.  [Polycythemia vera, complicated by myocardial infarction].

Authors:  V A Rykov; O N Letunova
Journal:  Arkh Patol       Date:  1995 May-Jun

10.  Acute myocardial infarction revealing a polycythemia vera.

Authors:  Adel Gouri; Amina Yakhlef; Aoulia Dekaken; Ahmed Aymen Bentorki
Journal:  Ann Biol Clin (Paris)       Date:  2012 Jul-Aug       Impact factor: 0.459

View more
  3 in total

1.  A Case Report of Severe Dehydration Associated With Acute Kidney Injury Causing Acute ST-Segment Elevation Myocardial Infarction.

Authors:  Hosam Zaky; Sadeq Tabatabai; Parveez A Zarger; Jasem M Al Hashmi
Journal:  Cureus       Date:  2022-05-22

2.  Acute Myocardial Infarction as First Onset of Polycythemia Vera.

Authors:  Caroline Ferreira da Silva Mazeto Pupo da Silveira; Lívia Beatriz Santos Limonta Vitali; Fabiana Garcia Faustino; Alejandra Del Carmen Villanueva Maurício; Renato Teixeira; Silméia Garcia Zanati Bazan
Journal:  Arq Bras Cardiol       Date:  2020-05-18       Impact factor: 2.000

3.  No-reflow phenomenon during percutaneous coronary intervention in a patient with polycythemia vera: A case report.

Authors:  Yudi Her Oktaviono; Suryo Ardi Hutomo; Makhyan Jibril Al-Farabi
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.